Advertisement PSS World and Novartis sign vaccine sales agreement - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

PSS World and Novartis sign vaccine sales agreement

PSS World Medical has entered into a unique agreement with Novartis Vaccines and Diagnostics, to act, under a fee-for-service arrangement, as a sales agent and to provide logistical and related services to its customers for the sale of Novartis's Fluvirin influenza virus vaccine.

The company’s physician business, Physician Sales & Service (PSS), expects to market and sell a minimum of two million doses of Fluvirin on behalf of Novartis Vaccines to office-based physicians in the upcoming 200-2009 influenza season. The company also said that, orders may be placed for Fluvirin influenza virus vaccine for the 2008-2009 influenza season through Physician Sales & Service offices located nationwide.